A COMPARATIVE STUDY OF SERUM ERRITIN LEVELS AND INSULIN RESISTANCE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME

Main Article Content

Dr. Portia Dewan
Dr. Sandipan Mistry
Dr Aparna Debbarma

Keywords

Insulin resistance, Polycystic Ovary Syndrome, BMI and hyperandrogenism

Abstract

Introduction: Five to ten percent of women in the reproductive age range suffer with PCOS, one of the most common endocrine disorders. It is a diverse condition marked by hyperandrogenism and persistent anovulation. PCOS is linked to obesity and insulin resistance in addition to ovulatory dysfunction and hyperandrogenic characteristics.


Aims: To analyse the fasting serum levels of ferritin, insulin, iron, glucose and whole blood HbA1c in patients with PCOS and in normal women without PCOS. To measure the BMI, waist circumference and BP in the cases and control groups. To compare the parameters mentioned  in  cases  and  controls  for  any  significant   statistical differences.


Materials & Methods: Study type Case control study, Outdoor patient of Vani Vilas  Hospital , Bangalore, study period from November, 2015 to September, 2017 and total sample size was  60


Result: In Cases Group, 6 (20.0%) patients were ≤25 BMI (kg/m2), 15 (50.0%) patients were 25-30 BMI(kg/m2), 9 (3.0%) patients were ≥30 BMI (kg/m2).In Controls Group, 20 (66.7%) patients were ≤25 BMI (kg/m2), 7 (23.3%) patients were 25-30 BMI(kg/m2), 3 (10.0%) patients were ≥30 BMI (kg/m2).Association of BMI (kg/m2) with cases and controls Group was  statistically  significant (p=0.0015)


Conclusion: Iron metabolism may be involved in the pathogenesis of PCOS, as indicated by elevated blood ferritin levels and their association with insulin resistance. To enhance metabolic outcomes for PCOS patients, more research is necessary to examine the mechanistic connection and assess treatment approaches that target iron metabolism.

Abstract 44 | pdf Downloads 10

References

1. Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Archives of internal medicine. 2006 Oct 23;166(19):2081-6.
2. Möhlig M, Spranger J, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Moltz L, Brabant G, Schöfl C. Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome. European journal of endocrinology. 2006 Feb;154(2):295-301.
3. Martinez-Garcia MA, Luque-Ramirez M, San-Millan JL, Escobar-Morreale HF. Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes care. 2009 Aug 1;32(8):1525-30.
4. Futterweit W. Polycystic ovary syndrome: clinical perspectives and management. Obstetrical & gynecological survey. 1999 Jun 1;54(6):403-13.
5. Ramezani Tehrani F, Minooee S, Azizi F. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. European journal of endocrinology. 2014 Aug;171(2):199- 207.
6. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine reviews. 1997 Dec 1;18(6):774-800.
7. Lerchbaum E, Schwetz V, Giuliani A, Obermayer-Pietsch B. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method. Human Reproduction. 2013 Sep 1;28(9):2537-44.
8. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicology and applied pharmacology. 2005 Jan 15;202(2):199-211.
9. Luque-Ramirez M, Alvarez-Blasco F, Botella-Carretero JI, Sanchon R, San Millan JL, Escobar-Morreale HF. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care. 2007 Sep 1;30(9):2309-13.
10. Tarkun İ, Çetinarslan B, Cantürk Z, Türemen E. The Plasma homocysteine concentrations and relationship with insulin resistance in young women with polycystic ovary syndrome. Turkish journal of Endocrinology and Metabolism. 2005;1:23-8.
11. Sheu WH, Chen YT, Lee WJ, Wang CW, Lin LY. A relationship between serum ferritin and the insulin resistance syndrome is present in non‐diabetic women but not in non‐diabetic men. Clinical endocrinology. 2003 Mar;58(3):380-5.
12. Luque-Ramírez M, Alvarez-Blasco F, Alpanes M, Escobar-Morreale HF. Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. The journal of clinical endocrinology & metabolism. 2011 Mar 1;96(3):846-52.
13. Salonen JT, Tuomainen TP, Nyyssönen K, Lakka HM, Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. Bmj. 1998 Sep 12;317(7160):727-30.